The below listed patent application was rejected by the USPTO on January 4, 2023.
The USPTO has now posted the Company's response to that non-final rejection.
Claim 1 is amended, Claims 18 - 22 are cancelled and Claims 23 - 27 are now added.
A lot of the rejection is tied to "failing to comply with the written description requirement".
The cancelled claims (18 - 22) are for an improper grouping of alternatives.
The claims have to do with the methods of using TLD1433 & TLD1824.
The modifications appear moderate but even so the USPTO now has up to 90 days
to say whether they accept them or not.
17/192,569 | T1081/20043:
SONODYNAMIC THERAPY USING SONODYNAMICALLY ACTIVATED COORDINATION COMPLEXES OF TRANSITION METALS AS SENSITIZING AGENTS
Public view Attorney Docket #
T1081/20043
Filing or 371 (c) date
03/04/2021
Status
Non Final Action Mailed 12/30/2022
Application type
Utility
Examiner
SAGAR S PATEL
Group art unit
1626
Class/subclass
514/492.000
AIA (first inventor to file)
Yes
Entity status
Small
Earliest publication #
US 2022-0296709 A1open_in_new
Earliest publication date
09/22/2022
Assignee for publication
- Confirmation #
5826
Intl. registration # (Hague)
-
Intl. registration publication date
-
Correspondence address
3000 - CAESAR RIVISE, PC
7 Penn Center, 12th Floor
1635 Market Street
Philadelphia, PA
UNITED STATES
Inventors
-
Arkady Mandel
North York (CA)
-
Roger Dumoulin-White
Toronto (CA)
-
Applicants
Theralase Technologies, Inc.
Toronto (CA)
Documents & transaction history
Showing 1 to 22 of 22 entries